These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7888849)

  • 21. Management of myocardial infarction from the patient.
    Rodgers KA
    N Z Med J; 1994 Apr; 107(975):140-1. PubMed ID: 7908426
    [No Abstract]   [Full Text] [Related]  

  • 22. Medical prophylaxis for the post myocardial infarct patient.
    Cohen LS
    Cardiol Clin; 1988 Feb; 6(1):173-8. PubMed ID: 2901909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic management of the myocardial infarction patient after discharge from the hospital.
    Rosman HS; Goldstein S
    Cardiovasc Clin; 1984; 14(3):127-37. PubMed ID: 6144387
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevention of recurrent myocardial infarct].
    Kallio V
    Duodecim; 1981; 97(5):227-30. PubMed ID: 6113128
    [No Abstract]   [Full Text] [Related]  

  • 25. [Secondary prevention following myocardial infarct].
    Follath F
    Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1177-80. PubMed ID: 2877482
    [No Abstract]   [Full Text] [Related]  

  • 26. [Infarction prophylaxis--prevention of the sudden heart death? An alternative].
    Gross F
    MMW Munch Med Wochenschr; 1982 May; 124(18):435-6. PubMed ID: 6124885
    [No Abstract]   [Full Text] [Related]  

  • 27. Improving aspirin prophylaxis after myocardial infarction in primary care: collaboration in multipractice audit between primary care audit group and health authority.
    Khunti K; Sorrie R; Jennings S; Farooqi A
    BMJ; 1999 Jul; 319(7205):297. PubMed ID: 10426745
    [No Abstract]   [Full Text] [Related]  

  • 28. Initiative raises use of interventions that prevent second heart attacks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2000 Jul; 11(14):8-10. PubMed ID: 11771563
    [No Abstract]   [Full Text] [Related]  

  • 29. General aspects of secondary prevention after myocardial infarction.
    Elmfeldt D; Wilhelmsen L; Vedin A; Wilhelmsson C; Hjalmarson A; Bergstrand R
    Adv Cardiol; 1978; (24):94-104. PubMed ID: 27952
    [No Abstract]   [Full Text] [Related]  

  • 30. Secondary prevention after myocardial infarction. Too many choices, which ones work?
    Deedwania PC; Carbajal EV
    Arch Intern Med; 1993 Feb; 153(3):285-8. PubMed ID: 8093996
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention of myocardial infarction by chemotherapy].
    Toshima H; Adachi K
    Nihon Rinsho; 1982; 40(11):2465-70. PubMed ID: 6130172
    [No Abstract]   [Full Text] [Related]  

  • 32. Trial is needed of ACE inhibitors plus beta blockers in survivors of myocardial infarction.
    McAlister FA
    BMJ; 1998 Sep; 317(7160):751. PubMed ID: 9732353
    [No Abstract]   [Full Text] [Related]  

  • 33. Audit suggests that use of aspirin is rising in coronary heart disease.
    King R; Denne J
    BMJ; 1995 Dec; 311(7018):1504. PubMed ID: 8520359
    [No Abstract]   [Full Text] [Related]  

  • 34. [Secondary prevention of myocardial infarct using beta-blockers].
    Vacheron A
    Bull Acad Natl Med; 1985 Mar; 169(3):369-73. PubMed ID: 2864119
    [No Abstract]   [Full Text] [Related]  

  • 35. Saving lives after myocardial infarction: the role of beta-adrenergic blockers.
    Frishman WH
    Mt Sinai J Med; 1990 Mar; 57(2):75-84. PubMed ID: 1973260
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-blockade after myocardial infarction--a statistical view.
    Lewis JA
    Br J Clin Pharmacol; 1982; 14 Suppl 1(Suppl 1):15S-21S. PubMed ID: 6126204
    [No Abstract]   [Full Text] [Related]  

  • 37. Commentary on NICE guidance for secondary prevention for patients following a myocardial infarction.
    Skinner JS; Minhas R
    Heart; 2007 Jul; 93(7):864-6. PubMed ID: 17569812
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of myocardial reinfarction. Recommendations based on results of drug trials.
    Flaker GC; Singh VN
    Postgrad Med; 1993 Nov; 94(6):94-8, 102-4. PubMed ID: 7901845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of beta-blockers in the secondary prevention of acute myocardial infarcts. Status and recomendations].
    Jurgensen HJ
    Ugeskr Laeger; 1984 Mar; 146(12):863-8. PubMed ID: 6144204
    [No Abstract]   [Full Text] [Related]  

  • 40. Regional variation in the treatment and outcomes of myocardial infarction: investigating New England's advantage.
    Krumholz HM; Chen J; Rathore SS; Wang Y; Radford MJ
    Am Heart J; 2003 Aug; 146(2):242-9. PubMed ID: 12891191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.